Cargando…
Ketone Ester Treatment Improves Cardiac Function and Reduces Pathologic Remodeling in Preclinical Models of Heart Failure
Accumulating evidence suggests that the failing heart reprograms fuel metabolism toward increased utilization of ketone bodies and that increasing cardiac ketone delivery ameliorates cardiac dysfunction. As an initial step toward development of ketone therapies, we investigated the effect of chronic...
Autores principales: | Yurista, Salva R., Matsuura, Timothy R., Silljé, Herman H.W., Nijholt, Kirsten T., McDaid, Kendra S., Shewale, Swapnil V., Leone, Teresa C., Newman, John C., Verdin, Eric, van Veldhuisen, Dirk J., de Boer, Rudolf A., Kelly, Daniel P., Westenbrink, B. Daan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819534/ https://www.ncbi.nlm.nih.gov/pubmed/33356362 http://dx.doi.org/10.1161/CIRCHEARTFAILURE.120.007684 |
Ejemplares similares
-
Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction
por: Yurista, Salva R., et al.
Publicado: (2020) -
SGLT2 Inhibitors and Ketone Metabolism in Heart Failure
por: Saucedo-Orozco, Huitzilihuitl, et al.
Publicado: (2022) -
Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?
por: Yurista, Salva R., et al.
Publicado: (2020) -
The erythropoietin receptor expressed in skeletal muscle is essential for mitochondrial biogenesis and physiological exercise
por: Nijholt, Kirsten T., et al.
Publicado: (2021) -
Effects of Sodium–Glucose Co-transporter 2 Inhibition with Empaglifozin on Renal Structure and Function in Non-diabetic Rats with Left Ventricular Dysfunction After Myocardial Infarction
por: Yurista, Salva R., et al.
Publicado: (2020)